YARW

Yarrow Bioscience Inc

YARW | NASDAQ

Price Alert Chart Builder DCF Calculator

$19.90

-$0.10 (-0.50%)

At close: Oct 30, 2026, 4:00 PM ET

$19.90

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $185.16M

Enterprise Value $162.23M

Beta 2.08

Average Volume 17.94K

Shares Outstanding (Diluted) 858K

Shares Change YoY 0.33%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US92941V4077

Price Performance

Price Change 1M -11.6%

Price Change 3M -43.2%

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -32.1%

1Y CAGR (ann.) 15.8%

5Y CAGR (ann.) -54.5%

All-Time CAGR -62.3%

Valuation

PE Ratio -0.85

Forward PE N/A

PEG Ratio -0.01

Forward PEG -0.01

PS Ratio 384.14

Forward PS 375.50

PB Ratio 8.39

P/FCF Ratio -10.93

P/Adj. FCF Ratio -10.05

P/OCF Ratio -1.01

EV/Sales 336.58

EV/EBIT -8.60

EV/EBITDA -8.61

EV/FCF -9.58

Earnings Yield -117.8%

FCF Yield -9.2%

Adj. FCF Yield -9.9%

Financial Health

Net Cash $22.93M

Total Debt $0

Cash & Short-Term Investments $22.93M

Total Assets $23.6M

Current Ratio 15.26

Quick Ratio 15.26

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 25.22

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 97.5%

Operating Profit Margin -4134.6%

EBITDA Margin -3909.3%

Net Profit Margin -3881.5%

FCF Margin -3513.1%

Adj. FCF Margin -3822.2%

SBC / Revenue 309.1%

SBC Impact (per share) -8.8%

Returns

Return on Assets -79.3%

Return on Equity -70.2%

Return on Invested Capital -90.3%

Return on Capital Employed -90.3%

Return on Tangible Assets -79.3%

Historical Growth (CAGR)

Revenue CAGR 3Y 5.8%

Revenue CAGR 5Y -43.1%

Revenue CAGR 10Y -15.1%

EPS CAGR 3Y 80.0%

EPS CAGR 5Y 67.1%

EPS CAGR 10Y 22.4%

FCF CAGR 3Y 17.6%

FCF CAGR 5Y 13.6%

FCF CAGR 10Y 0.1%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y -108.8%

Revenue Growth Next 3Y -4.0%

Earnings Date Nov 5, 2026

EPS Estimate (next Q) -$16.00

EPS Growth Est (next Q) 9311.8%

Revenue Est (next Q) $200K

Revenue Growth Est (next Q) 18.3%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $5.75

Price Target Upside -71.1%

Cash Flow

Operating Cash Flow $-16.93M

Free Cash Flow $-16.93M

Adj. Free Cash Flow $-18.42M

FCF Per Share -$19.74

OCF Per Share -$19.74

OCF/S Ratio -3513.1%

Income Statement

Revenue $482K

Gross Profit $470K

Operating Income $-19.93M

EBITDA $-18.85M

Net Income $-18.71M

EPS (Diluted) -$23.45

Revenue / Employee $48.2K

Profit / Employee $-1.87M

Employees 10